Cargando…

Cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy

Many cases of cutaneous vasculitis are drug-induced with histology revealing leukocytoclastic vasculitis (LCV). We present a case of levofloxacin-associated LCV successfully treated with prednisone and cessation of the offending drug. Although case reports describe a link between LCV and older fluor...

Descripción completa

Detalles Bibliográficos
Autores principales: Blyth, Dana M., Markelz, Elizabeth, Okulicz, Jason F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892663/
https://www.ncbi.nlm.nih.gov/pubmed/24470918
http://dx.doi.org/10.4081/idr.2012.e11
_version_ 1782299566144487424
author Blyth, Dana M.
Markelz, Elizabeth
Okulicz, Jason F.
author_facet Blyth, Dana M.
Markelz, Elizabeth
Okulicz, Jason F.
author_sort Blyth, Dana M.
collection PubMed
description Many cases of cutaneous vasculitis are drug-induced with histology revealing leukocytoclastic vasculitis (LCV). We present a case of levofloxacin-associated LCV successfully treated with prednisone and cessation of the offending drug. Although case reports describe a link between LCV and older fluoroquinolones, such as ciprofloxacin and ofloxacin, recent reports have implicated the newer fluoroquinolone levofloxacin. Recognition of fluoroquinolone-induced cutaneous vasculitis is important as continuation or re-exposure of the offending agent may have life-threatening consequences.
format Online
Article
Text
id pubmed-3892663
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher PAGEPress Publications
record_format MEDLINE/PubMed
spelling pubmed-38926632014-01-27 Cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy Blyth, Dana M. Markelz, Elizabeth Okulicz, Jason F. Infect Dis Rep Case Report Many cases of cutaneous vasculitis are drug-induced with histology revealing leukocytoclastic vasculitis (LCV). We present a case of levofloxacin-associated LCV successfully treated with prednisone and cessation of the offending drug. Although case reports describe a link between LCV and older fluoroquinolones, such as ciprofloxacin and ofloxacin, recent reports have implicated the newer fluoroquinolone levofloxacin. Recognition of fluoroquinolone-induced cutaneous vasculitis is important as continuation or re-exposure of the offending agent may have life-threatening consequences. PAGEPress Publications 2012-01-30 /pmc/articles/PMC3892663/ /pubmed/24470918 http://dx.doi.org/10.4081/idr.2012.e11 Text en ©Copyright D.M. Blyth et al., 2012 This work is licensed under a Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Licensee PAGEPress, Italy
spellingShingle Case Report
Blyth, Dana M.
Markelz, Elizabeth
Okulicz, Jason F.
Cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy
title Cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy
title_full Cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy
title_fullStr Cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy
title_full_unstemmed Cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy
title_short Cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy
title_sort cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892663/
https://www.ncbi.nlm.nih.gov/pubmed/24470918
http://dx.doi.org/10.4081/idr.2012.e11
work_keys_str_mv AT blythdanam cutaneousleukocytoclasticvasculitisassociatedwithlevofloxacintherapy
AT markelzelizabeth cutaneousleukocytoclasticvasculitisassociatedwithlevofloxacintherapy
AT okuliczjasonf cutaneousleukocytoclasticvasculitisassociatedwithlevofloxacintherapy